Literature DB >> 20388756

Identifying recent Mycobacterium tuberculosis transmission in the setting of high HIV and TB burden.

Junior Mutsvangwa1, Kerry A Millington, Kathryn Chaka, Tafadzwa Mavhudzi, Yin-Bun Cheung, Peter R Mason, Anthony E Butterworth, Elizabeth L Corbett, Ajit Lalvani.   

Abstract

BACKGROUND: Accurate diagnosis of latent tuberculosis infection (LTBI) in recently exposed HIV-infected tuberculosis (TB) contacts is a public health priority because of the high risk of progression to active TB but is hampered by the high background prevalence of LTBI in high-burden populations and poor sensitivity of tuberculin skin testing (TST) in HIV co-infection.
METHODS: The prevalence of LTBI in 222 recent household contacts of TB cases and 176 household contacts of community controls without TB in Harare, Zimbabwe were compared using TST and interferon gamma enzyme-linked immunospot (ELISpot) responses to ESAT-6 (early secretory antigenic target-6) and CFP-10 (culture filtrate protein-10). TST and ELISpot results were correlated with markers of recent TB exposure and the impact of HIV co-infection was assessed.
RESULTS: In this high-incidence population, the proportion of ELISpot-positive contacts was not significantly different from community controls. However, ELISpot, unlike TST, revealed a higher prevalence of LTBI in recent contacts of sputum smear-positive cases than in contacts of controls. ELISpot results correlated significantly with positive sputum smear and culture status of the index case (adjusted OR 2.40, CI 1.12 to 5.14), even in the subgroup of HIV-infected contacts (adjusted OR 5.36, CI 1.11 to 25.93). and were independent of contacts' HIV status. TST results were also associated with positive smear and culture status of the index case (adjusted OR 4.41, CI 1.82 to 10.67) but were negatively associated with contacts' HIV status (adjusted OR 0.25, CI 0.10 to 0.60).
CONCLUSIONS: Contact investigations in high-burden populations should focus on contacts of sputum smear-positive cases in whom recent infection can be detected by ELISpot, even in the presence of HIV co-infection.

Entities:  

Mesh:

Year:  2010        PMID: 20388756     DOI: 10.1136/thx.2009.124891

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  12 in total

1.  Enzyme-linked immunospot assay (ELISPOT): Quantification of Th-1 cellular immune responses against microbial antigens.

Authors:  Isfahan R Chambers; Tiffany R Cone; Kyra Oswald-Richter; Wonder P Drake
Journal:  J Vis Exp       Date:  2010-11-23       Impact factor: 1.355

Review 2.  Diagnosing latent tuberculosis in high-risk individuals: rising to the challenge in high-burden areas.

Authors:  Victoria O Kasprowicz; Gavin Churchyard; Stephen D Lawn; S Bertel Squire; Ajit Lalvani
Journal:  J Infect Dis       Date:  2011-11-15       Impact factor: 5.226

3.  Community-based evaluation of immigrant tuberculosis screening using interferon γ release assays and tuberculin skin testing: observational study and economic analysis.

Authors:  Manish Pareek; Marion Bond; Jennifer Shorey; Suranjith Seneviratne; Margaret Guy; Peter White; Ajit Lalvani; Onn Min Kon
Journal:  Thorax       Date:  2012-06-12       Impact factor: 9.139

Review 4.  Contact investigation for tuberculosis: a systematic review and meta-analysis.

Authors:  Gregory J Fox; Simone E Barry; Warwick J Britton; Guy B Marks
Journal:  Eur Respir J       Date:  2012-08-30       Impact factor: 16.671

5.  Risk factors associated with positive QuantiFERON-TB Gold In-Tube and tuberculin skin tests results in Zambia and South Africa.

Authors:  Kwame Shanaube; James Hargreaves; Katherine Fielding; Ab Schaap; Katherine-Anne Lawrence; Bernadette Hensen; Charalambos Sismanidis; Angela Menezes; Nulda Beyers; Helen Ayles; Peter Godfrey-Faussett
Journal:  PLoS One       Date:  2011-04-04       Impact factor: 3.240

6.  Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis.

Authors:  Manish Pareek; John P Watson; L Peter Ormerod; Onn Min Kon; Gerrit Woltmann; Peter J White; Ibrahim Abubakar; Ajit Lalvani
Journal:  Lancet Infect Dis       Date:  2011-04-20       Impact factor: 25.071

7.  Comparison of screening strategies to improve the diagnosis of latent tuberculosis infection in the HIV-positive population: a cohort study.

Authors:  Katrina M Pollock; Herman Tam; Lisa Grass; Sharleen Bowes; Graham S Cooke; Manish Pareek; Damien Montamat-Sicotte; Moses Kapembwa; Graham P Taylor; Ajit Lalvani
Journal:  BMJ Open       Date:  2012-03-01       Impact factor: 2.692

8.  Latent TB infection diagnosis in population exposed to TB subjects in close and poor ventilated high TB endemic zone in India.

Authors:  Rajpal S Kashyap; Amit R Nayak; Hari M Gaherwar; Aliabbas A Husain; Seema D Shekhawat; Ruchika K Jain; Milind S Panchbhai; Dhananjay V Raje; Hemant J Purohit; Girdhar M Taori; Hatim F Daginawala
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

9.  Determining Mycobacterium tuberculosis infection among BCG-immunised Ugandan children by T-SPOT.TB and tuberculin skin testing.

Authors:  Gyaviira Nkurunungi; Jimreeves E Lutangira; Swaib A Lule; Hellen Akurut; Robert Kizindo; Joseph R Fitchett; Dennison Kizito; Ismail Sebina; Lawrence Muhangi; Emily L Webb; Stephen Cose; Alison M Elliott
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

Review 10.  Current methods in the molecular typing of Mycobacterium tuberculosis and other mycobacteria.

Authors:  Tomasz Jagielski; Jakko van Ingen; Nalin Rastogi; Jarosław Dziadek; Paweł K Mazur; Jacek Bielecki
Journal:  Biomed Res Int       Date:  2014-01-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.